Dipeptidyl peptidase- IV inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine model
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 73, 186-195
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Stress Augments Insulin Resistance and Prothrombotic StateDiabetes, 2012
- Mechanisms of action of the dipeptidyl peptidase‐4 inhibitor vildagliptin in humansDiabetes, Obesity and Metabolism, 2011
- Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic SyndromeDiabetes, 2011
- Psychophysiological risk markers of cardiovascular diseaseNeuroscience & Biobehavioral Reviews, 2010
- γ-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient miceBiochemical and Biophysical Research Communications, 2009
- Critical Role of Endothelial Notch1 Signaling in Postnatal AngiogenesisCirculation Research, 2007
- Behavioral characterization of CD26 deficient mice in animal tests of anxiety and antidepressant-like activityBehavioural Brain Research, 2006
- DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in miceBrain Research, 2005
- Increased Expression of Plasminogen Activator Inhibitor-1 with Fibrin Deposition in a Murine Model of Aging, "Klotho" MouseSeminars in Thrombosis and Hemostasis, 2002
- Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cellsOncogene, 2000